{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+1&page=2", "query": { "intervention": "Vehicle 1", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+1&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T09:13:15.331Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03798561", "title": "Study to Evaluate ASN008 Topical Gel (TG)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Dermatitis, Atopic", "Pruritus", "Dermatitis Eczema" ], "interventions": [ { "name": "ASN008 TG", "type": "DRUG" }, { "name": "Placebo TG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Asana BioSciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 24, "start_date": "2019-01-14", "completion_date": "2020-03-20", "has_results": false, "last_update_posted_date": "2023-05-09", "last_synced_at": "2026-09-26T09:13:15.331Z", "location_count": 4, "location_summary": "Cortland, New York • High Point, North Carolina • San Antonio, Texas + 1 more", "locations": [ { "city": "Cortland", "state": "New York" }, { "city": "High Point", "state": "North Carolina" }, { "city": "San Antonio", "state": "Texas" }, { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03798561" }, { "nct_id": "NCT04030962", "title": "A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Dry Eye Disease", "Dry Eye Syndrome" ], "interventions": [ { "name": "AGN-242428", "type": "DRUG" }, { "name": "AGN-231868", "type": "DRUG" }, { "name": "AGN-242428 Vehicle", "type": "OTHER" }, { "name": "AGN-231868 Vehicle", "type": "OTHER" }, { "name": "Lifitegrast 5% Ophthalmic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 292, "start_date": "2020-03-04", "completion_date": "2022-03-18", "has_results": true, "last_update_posted_date": "2025-05-20", "last_synced_at": "2026-09-26T09:13:15.331Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Newport Beach, California • Colorado Springs, Colorado + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Andover", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04030962" }, { "nct_id": "NCT01413542", "title": "Pharmacogenetics of Ace Inhibitor-Associated Angioedema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension", "Diabetes Type 2" ], "interventions": [ { "name": "Sitagliptin (DPP4 inhibitor)", "type": "DRUG" }, { "name": "Substance P,", "type": "DRUG" }, { "name": "bradykinin", "type": "DRUG" }, { "name": "enalaprilat (ACE inhibitor)", "type": "DRUG" }, { "name": "Glucagon-like peptide 1", "type": "DRUG" }, { "name": "brain natriuretic peptide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 44, "start_date": "2011-11", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2015-11-04", "last_synced_at": "2026-09-26T09:13:15.331Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01413542" }, { "nct_id": "NCT03565861", "title": "Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Safety Issues" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "NP10679", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurop Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 48, "start_date": "2018-04-06", "completion_date": "2018-10-10", "has_results": false, "last_update_posted_date": "2019-03-13", "last_synced_at": "2026-09-26T09:13:15.331Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03565861" }, { "nct_id": "NCT03263273", "title": "Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rosacea", "Papulopustular Rosacea" ], "interventions": [ { "name": "1% Topical Minocycline Gel", "type": "DRUG" }, { "name": "3% Topical Minocycline Gel", "type": "DRUG" }, { "name": "Topical Vehicle Gel", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Hovione Scientia Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 270, "start_date": "2017-10-30", "completion_date": "2019-07-01", "has_results": false, "last_update_posted_date": "2019-11-08", "last_synced_at": "2026-09-26T09:13:15.331Z", "location_count": 23, "location_summary": "Bryant, Arkansas • Rogers, Arkansas • Fremont, California + 17 more", "locations": [ { "city": "Bryant", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Fremont", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03263273" }, { "nct_id": "NCT06128369", "title": "A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Inflammation Eye Pain", "Postoperative Cataract" ], "interventions": [ { "name": "OCS-01", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Oculis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 117, "start_date": "2023-12-18", "completion_date": "2024-05-09", "has_results": true, "last_update_posted_date": "2026-07-30", "last_synced_at": "2026-09-26T09:13:15.331Z", "location_count": 24, "location_summary": "Glendale, California • Inglewood, California • Newport Beach, California + 21 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Tamarac", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06128369" }, { "nct_id": "NCT01293552", "title": "Clinical Trial To Evaluate ANT-1207 In Subjects With Acne", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "ANT-1207", "type": "BIOLOGICAL" }, { "name": "Vehicle", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Anterios Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 72, "start_date": "2011-01", "completion_date": "2012-07", "has_results": false, "last_update_posted_date": "2013-07-04", "last_synced_at": "2026-09-26T09:13:15.331Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Miami, Florida • West Palm Beach, Florida + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Miami", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Snellville", "state": "Georgia" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01293552" }, { "nct_id": "NCT00343187", "title": "A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rash", "Non-small-Cell Lung Cancer" ], "interventions": [ { "name": "ACZONE (dapsone) Gel, 5%", "type": "DRUG" }, { "name": "Vehicle Control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2006-06", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2011-05-30", "last_synced_at": "2026-09-26T09:13:15.331Z", "location_count": 3, "location_summary": "Chicago, Illinois • Hershey, Pennsylvania • Philadelphia, Pennsylvania", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Hershey", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00343187" }, { "nct_id": "NCT03745638", "title": "Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Ruxolitinib Cream", "type": "DRUG" }, { "name": "Vehicle Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 631, "start_date": "2018-12-20", "completion_date": "2020-12-01", "has_results": true, "last_update_posted_date": "2023-09-28", "last_synced_at": "2026-09-26T09:13:15.331Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Fountain Valley, California + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03745638" }, { "nct_id": "NCT05424471", "title": "Preventing Early Childhood Obesity, Part 1: Long-term Follow-up", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Water; Lack of", "Childhood Obesity", "Feeding Behavior", "Mother-Child Relations", "Dietary Habits" ], "interventions": [ { "name": "Family Spirit Nurture (FSN)", "type": "BEHAVIORAL" }, { "name": "Control Group - Vehicle Safety", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "FEMALE", "summary": "13 Years and older · Female only" }, "enrollment_count": 110, "start_date": "2021-05-01", "completion_date": "2023-08-15", "has_results": false, "last_update_posted_date": "2023-08-21", "last_synced_at": "2026-09-26T09:13:15.331Z", "location_count": 1, "location_summary": "Shiprock, New Mexico", "locations": [ { "city": "Shiprock", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT05424471" } ] }